Abstract
BackgroundOsteoncrosis (ON) is reputed to be one of the most disabling complications following Corticosteroid(CS) medication. However, evidence regarding risk of asymptomatic prevalence among different diseases and the impact of variable...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
